EBA
TWST icon

Eagle Bay Advisors’s Twist Bioscience TWST Stock Holding History

Eagle Bay Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-46
Closed -$2.14K – 889
2024
Q4 		$2.14K Hold
46
– – ﹤0.01% 868
2024
Q3 		$2.08K Hold
46
– – ﹤0.01% 1223
2024
Q2 		$2.27K Hold
46
– – ﹤0.01% 868
2024
Q1 		$1.58K Hold
46
– – ﹤0.01% 905
2023
Q4 		$1.7K Hold
46
– – ﹤0.01% 759
2023
Q3 		$932 Hold
46
– – ﹤0.01% 803
2023
Q2 		$941 Hold
46
– – ﹤0.01% 806
2023
Q1 		$694 Hold
46
– – ﹤0.01% 852
2022
Q4 		$1.09K Hold
46
– – ﹤0.01% 818
2022
Q3 		$2K Hold
46
– – ﹤0.01% 783
2022
Q2 		$1.61K Buy
+46
New +$1.63K ﹤0.01% 849
2022
Q1 		– Sell
-46
Closed -$4K – 932
2021
Q4 		$4K Buy
+46
New +$4.72K ﹤0.01% 844

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Eagle Bay Advisors's TWST Position: Q1 2025 in Review

Eagle Bay Advisors sold out of Twist Bioscience (TWST) in Q1 2025, closing a stake of 46 shares — an estimated $2.14K sold.

Eagle Bay Advisors first reported a position in TWST in Q4 2021 and held it in 12 quarters. The position peaked at $4K in Q4 2021. 262 funds tracked by Wall St. Rank hold TWST as of Q1 2025.

  • Eagle Bay Advisors reported no remaining Twist Bioscience position as of Q1 2025 after selling out during the quarter.
  • Eagle Bay Advisors sold 46 Twist Bioscience shares in Q1 2025, an estimated $2.14K.
  • Eagle Bay Advisors first reported a position in Twist Bioscience in Q4 2021 and held it in 12 quarters.
  • Eagle Bay Advisors's Twist Bioscience position peaked at $4K in Q4 2021.
  • 262 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2025.

Based on Eagle Bay Advisors's 13F filing for Q1 2025, filed 5 May 2025.